These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...

The Boston-based company's new medication, called Journavx, is being placed on a tier that means it might be costlier than ...

Positive data from a pair of acute pain studies convinced the company that its drug, which works differently than existing ...

Optum Rx, the pharmacy benefit manager owned by UnitedHealth Group, placed Journavx on some of its commercial formularies in ...